Modulation of inhibition of return by the dopamine D2 receptor agonist bromocriptine depends on individual DAT1 genotype

Cerebral Cortex

Volumn 22, Issue 5, 2012, Pages 1133-1138

  Rokem, Ariel ^a   Landau, Ayelet N ^a   Prinzmetal, William ^a   Wallace, Deanna L ^a   Silver, Michael A ^a,b   D'Esposito, Mark ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DAT1; dopamine; inhibition of return; striatum; visual attention

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE TRANSPORTER; PLACEBO;

ADULT; ALLELE; ARTICLE; ATTENTION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORPUS STRIATUM; CROSSOVER PROCEDURE; DOPAMINERGIC TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; TASK PERFORMANCE;

ATTENTION; BROMOCRIPTINE; CORPUS STRIATUM; CROSS-OVER STUDIES; DOPAMINE; DOPAMINE AGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOUBLE-BLIND METHOD; FEMALE; GENOTYPE; HUMANS; MALE; NEURAL INHIBITION; REACTION TIME; RECEPTORS, DOPAMINE D2; VISUAL PERCEPTION; YOUNG ADULT;

EID: 84860206473     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhr185     Document Type: Article

References (44)

1. Camps M, Cortés R, Gueye B, Probst A, Palacios JM. 1989. Dopamine receptors in human brain: autoradiographic distribution of D2 sites. Neuroscience. 28: 275-290. (Pubitemid 19053074)
2. Cavanaugh J, Wurtz RH. 2004. Subcortical modulation of attention counters change blindness. J Neurosci. 24: 11236-11243. (Pubitemid 39658258)
3. Colzato LS, Hommel B. 2009. Recreational use of cocaine eliminates inhibition of return. Neuropsychology. 23: 125-129.
4. Colzato LS, Pratt J, Hommel B. 2010. Dopaminergic control of attentional flexibility: inhibition of return is associated with the dopamine transporter gene (DAT1). Front Hum Neurosci. 4: 53.
5. Cools R, D'Esposito M. 2009. Dopaminergic modulation of flexible cognitive control in humans. In: Björklund A, Dunnett SB, Iversen LL, Iversen SD, editors. Dopamine handbook. Oxford: Oxford University Press.
6. Cools R, D'Esposito M. 2011. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol Psychiatry. 69: e113-e125.
7. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. 2009. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci. 29: 1538-1543.
8. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M. 2008. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci. 28: 1208-1212. (Pubitemid 351186336)
9. Cools R, Robbins TW. 2004. Chemistry of the adaptive mind. Philos Transact A Math Phys Eng Sci. 362: 2871-2888. (Pubitemid 40004422)
10. Cools R, Sheridan M, Jacobs E, D'Esposito M. 2007. Impulsive personality predicts dopamine-dependent changes in frontostriatal activity during component processes of working memory. J Neurosci. 27: 5506-5514. (Pubitemid 46790174)
11. Dalley JW, Fryer TD, Brichard L, Robinson ES, Theobald DE, Lääne K, Peña Y, Murphy ER, Shah Y, Probst K, et al. 2007. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science. 315: 1267-1270. (Pubitemid 46364262)
12. Davie CA. 2008. A review of Parkinson's disease. Br Med Bull. 86: 109-127. (Pubitemid 351809630)
13. Dorris MC, Klein RM, Everling S, Munoz DP. 2002. Contribution of the primate superior colliculus to inhibition of return. J Cogn Neurosci. 14: 1256-1263. (Pubitemid 35305829)
14. Fecteau JH, Munoz DP. 2005. Correlates of capture of attention and inhibition of return across stages of visual processing. J Cogn Neurosci. 17: 1714-1727.
15. Fillmore MT, Rush CR, Abroms BD. 2005. d-Amphetamine-induced enhancement of inhibitory mechanisms involved in visual search. Exp Clin Psychopharmacol. 13: 200-208. (Pubitemid 41330633)
16. Filoteo JV, Delis DC, Salmon DP, Demadura T, Roman MJ, Shults CW. 1997. An examination of the nature of attentional deficits in patients with Parkinson's disease: evidence from a spatial orienting task. J Int Neuropsychol Soc. 3: 337-347.
17. Gerfen CR, Surmeier DJ. 2011. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci. 34: 441-466.
18. Gonon FG, Buda MJ. 1985. Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum. Neuroscience. 14: 765-774. (Pubitemid 15112239)
19. Heal D, Cheetham S, Smith S. 2009. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety. Neuropharmacology. 57: 608-618.
20. Hikosaka O, Sakamoto M, Usui S. 1989. Functional properties of monkey caudate neurons. II. Visual and auditory responses. J Neurophysiol. 61: 799-813. (Pubitemid 19111972)
21. Hikosaka O, Takikawa Y, Kawagoe R. 2000. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 80: 953-978. (Pubitemid 30452008)
22. Kimberg DY, D'Esposito M, Farah MJ. 1997. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport. 8: 3581-3585. (Pubitemid 27497487)
23. Klein RM. 2000. Inhibition of return. Trends Cogn Sci. 4: 138-147. (Pubitemid 30182530)
24. Lepsien J, Pollmann S. 2002. Covert reorienting and inhibition of return: an event-related fMRI study. J Cogn Neurosci. 14: 127-144. (Pubitemid 34113701)
25. Maruya H, Watanabe Y, Okita M, Lawlor GF, Utsumi H, Niitsuma T. 2003. Inhibitory effects of D2 agonists by striatal injection on excessive release of dopamine and hyperactivity induced by Bay K 8644 in rats. Neuroscience. 118: 1091-1098. (Pubitemid 36561196)
26. Mayer AR, Seidenberg M, Dorflinger JM, Rao SM. 2004. An event-related fMRI study of exogenous orienting: supporting evidence for the cortical basis of inhibition of return? J Cogn Neurosci. 16: 1262-1271. (Pubitemid 39274452)
27. Meador-Woodruff JH, Damask SP, Wang J, Haroutunian V, Davis KL, Watson SJ. 1996. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 15: 17-29. (Pubitemid 26233387)
28. Mehta MA, Riedel WJ. 2006. Dopaminergic enhancement of cognitive function. Curr Pharm Des. 12: 2487-2500.
29. Mill J, Asherson P, Browes C, D'Souza U, Craig I. 2002. Expression of the dopamine transporter gene is regulated by the 3' UTR VNTR: evidence from brain and lymphocytes using quantitative RT-PCR. Am J Med Genet. 114: 975-979. (Pubitemid 35379243)
30. Posner MI, Cohen Y. 1984. Components of visual orienting. In: Bouma H, Bouwhais DG, editors. Attention and performance X: control of language processes. Hillsdale (NJ): Erlbaum. p. 531-556.
31. Possin KL, Filoteo JV, Song DD, Salmon DP. 2009. Space-based but not object-based inhibition of return is impaired in Parkinson's disease. Neuropsychologia. 47: 1694-1700.
32. Price P, Debono A, Parkes JD, Marsden CD, Rosenthaler J. 1978. Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism. Br J Clin Pharmacol. 6: 303-309. (Pubitemid 9033747)
33. Prinzmetal W, McCool C, Park S. 2005. Attention: reaction time and accuracy reveal different mechanisms. J Exp Psychol Gen. 134: 73-92. (Pubitemid 40251389)
34. Radad K, Gille G, Rausch WD. 2005. Short review on dopamine agonists: insight into clinical and research studies relevant to Parkinson's disease. Pharmacol Rep. 57: 701-712.
35. Rafal RD, Posner MI, Walker JA, Friedrich FJ. 1984. Cognition and the basal ganglia. Separating mental and motor components of performance in Parkinson's disease. Brain. 107(Pt 4): 1083-1094. (Pubitemid 15182097)
36. Ro T, Rafal RD. 1999. Components of reflexive visual orienting to moving objects. Percept Psychophys. 61: 826-836.
37. Rokem A, Landau AN, Garg D, Prinzmetal W, Silver MA. 2010. Cholinergic enhancement increases the effects of voluntary attention but does not affect involuntary attention. Neuropsychopharmacology. 35: 2538-2544.
38. Sapir A, Soroker N, Berger A, Henik A. 1999. Inhibition of return in spatial attention: direct evidence for collicular generation. Nat Neurosci. 2: 1053-1054. (Pubitemid 30126361)
39. Seamans JK, Yang CR. 2004. The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol. 74: 1-58.
40. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci. 18: 2697-2708. (Pubitemid 28141815)
41. Volkow ND, Fowler JS, Wang GJ. 1999. Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol. 13: 337-345. (Pubitemid 30055177)
42. Wallace DL, Vytlacil JJ, Nomura EM, Gibbs SE, D'Esposito M. 2011. The dopamine agonist bromocriptine differentially affects fronto-striatal functional connectivity during working memory. Front Hum Neurosci. 5: 32.
43. Yamaguchi S, Kobayashi S. 1998. Contributions of the dopaminergic system to voluntary and automatic orienting of visuospatial attention. J Neurosci. 18: 1869-1878. (Pubitemid 28103094)
44. Yantis S, Jonides J. 1990. Abrupt visual onsets and selective attention: voluntary versus automatic allocation. J Exp Psychol Hum Percept Perform. 16: 121-134.